Radiation Dose Management Market

Radiation Dose Management Market [Product and Services: Software (Integrated Solution, Standalone Solution), Services; End-user: Hospitals, Ambulatory Care Settings, Research Organizations, Others] - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

Global Radiation Dose Management Market Outlook 2031

  • The industry was valued at US$ 237.8 Mn in 2022
  • It is estimated to advance at a CAGR of 14.8% from 2023 to 2031 and reach US$ 808.4 Mn by the end of 2031

Analyst Viewpoint

Growth in health concerns over radiation exposure and rise in use of diagnostic imaging modalities are fueling the radiation dose management market size. Radiation dose management enables optimum monitoring of dosage and high accuracy in results. Rise in number of pediatric imaging procedures is also propelling market progress.

Technological advancements and easy access to radiology screening are offering lucrative radiation dose management market opportunities to companies. Leading companies in the market are forming partnerships and alliances to increase their market presence. Increase in investments in research and development activities enables companies to offer precise dose management services to diagnosis centers.

Radiation Dose Management Market

Market Introduction

Radiation dose is the amount of energy from radiation that is actually absorbed by the body. It is important to monitor and track the amount of radiation dose injected into the body while conducting a medical procedure. Excessive dosage can create a hazardous impact on patients and also affect the results of a scan. Radiation dose management helps improve radiation protection in medical imaging and interventions. Detection of events, optimization, and imaging quality analysis are major tasks of radiation dose management.

Radiation dose management systems are widely utilized in medical imaging processes, including computed tomography, magnetic resonance imaging, and X-rays. Automatic registration and management of patient doses, information on recurrent examinations, and creation of dose reports are some of the major advantages of radiation dose management. Radiation doses help prevent adverse effects of radiation on the human body.

Increase in Health Concerns over Radiation Exposure Fostering Radiation Dose Management Market Growth

Excessive exposure to radiation can damage the DNA in cells. High doses of radiation can cause Acute Radiation Syndrome (ARS) or Cutaneous Radiation Injuries (CRI) and could also lead to cancer later in life. Radiation dose management helps to analyze the amount of doses required for medical imaging, depending on the duration, patient condition, and area to be diagnosed. Rise in various health concerns caused due to radiation exposure and increase in awareness about the benefits of these systems are major radiation dose management market drivers.

Increase in number of pediatric imaging procedures due to rise in health concerns among newborns is driving the demand for radiation dose management in pediatric radiology. Children are more susceptible to the potentially hazardous effects of ionizing radiation, thereby fostering market expansion.

Rise in Use of Diagnostic Imaging Modalities Augmenting Market Statistics

Diagnostic imaging modalities include radiotherapy, nuclear medicine, ultrasound, medical radiation, X-rays, angiography, and Magnetic Resonance Imaging (MRI). Radiation dose management is required to monitor the appropriate dosage level according to diagnosis procedure and patient’s age. Increase in availability of radiology diagnosis procedures and rise in use of diagnostic imaging modalities are fueling the radiation dose management market development. Moreover, increase in prevalence of cancer, orthopedic, and cardiac diseases is driving market dynamics.

According to the International Agency for Research on Cancer (IARC), in 2020, around 2.3 million women were diagnosed with breast cancer, with 685,000 fatalities recorded globally. The incidence of breast cancer is projected to reach 2.74 million cases by 2030.

Regional Outlook

As per the latest radiation dose management market insights, North America dominated the global market in 2022. Well-established healthcare infrastructure, increase in awareness about radiation exposure, and technological advancements in medical diagnosis are likely to propel the radiation dose management industry share held by the region during the forecast period.

According to American Cancer Society Recommendations for the Early Detection of Cancer, women aged 40-54 should undergo regular screening mammography starting at age 45. Thus, increase in number of cancer screening procedures is driving the radiation dose management market revenue.

Analysis of Key Players in Radiation Dose Management Industry

Leading companies providing radiation dose management services are collaborating with healthcare and diagnosis organizations to develop advanced services that ensure patient comfort and offer precise diagnosis results. Key players in the market are revising their marketing strategies in order to consolidate their position in the global market.

Some of the players in the industry are Landauer, Agfa-Gevaert Group, Sectra AB, INFINITT Healthcare Co. Ltd., Bayer AG, PACSHealth, LLC, Koninklijke Philips N.V., GE Healthcare, Thermo Fisher Scientific Inc., Medsquare SAS, Siemens, Fujifilm Holdings Corporation, and QAELUM NV.

Key players in the radiation dose management market report have been profiled based on various parameters including company overview, business segments, product portfolio, recent developments, business strategies, and financial overview.

Key Developments

  • In October 2022, Aspekt Solutions, a leader in medical physics services, acquired Landauer, a provider of physics and dosimetry services to radiation oncology clinics across the United States. This acquisition allows companies to provide extensive services to diagnostics centers and healthcare organizations across the U.S.
  • In September 2022, INFINITT Healthcare Co. Ltd., a leading developer of enterprise imaging solutions for healthcare, collaborated with Hamamatsu Corporation, a leading manufacturer of devices for the generation and measurement of visible, infrared, and ultraviolet light, to promote Hamamatsu whole slide scanners (NanoZoomers*) and INFINITT Digital Pathology Solution (IDPS) to its United States customers.

Radiation Dose Management Market Snapshot

Attribute Detail
Market Size in 2022 US$ 237.8 Mn
Market Forecast (Value) in 2031 US$ 808.4 Mn
Growth Rate (CAGR) 14.8%
Forecast Period 2023-2031
Historical Data Available for 2017-2021
Quantitative Tons US$ Mn for Value
Market Analysis It includes segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces Analysis, value chain analysis, and key trend analysis.
Competition Landscape
  • Market share analysis by company (2022)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy and recent developments, and key financials
Format Electronic (PDF) + Excel
Market Segmentation
  • Product and Services
    • Software
      • Integrated Solution
      • Standalone Solution
    • Services
  • Modality
    • Computed Tomography
    • Radiography and Mammography
    • Fluoroscopy and Interventional Imaging
    • Nuclear Medicine Scan
    • Others
  • Application
    • Oncology
    • Cardiology
    • Orthopedic
    • Others
  • End-user
    • Hospitals
    • Ambulatory Care Settings
    • Research Organizations
    • Others
Regions Covered
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Countries Covered
  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Japan
  • China
  • India
  • Australia & New Zealand
  • Brazil
  • Mexico
  • South Africa
  • GCC countries
Companies Profiled
  • Landauer
  • Agfa-Gevaert Group
  • Sectra AB
  • INFINITT Healthcare Co. Ltd.
  • Bayer AG
  • PACSHealth, LLC
  • Koninklijke Philips N.V.
  • GE Healthcare
  • Thermo Fisher Scientific Inc.
  • Medsquare SAS
  • Siemens
  • Fujifilm Holdings Corporation
  • QAELUM NV
Customization Scope Available upon request
Pricing Available upon request

Frequently Asked Questions

How big was the global radiation dose management market in 2022?

It was valued at US$ 237.8 Mn in 2022

How is the radiation dose management sector expected to grow by 2031?

It is projected to expand at a CAGR of 14.8% from 2023 to 2031

What are the key factors driving the demand for radiation dose management?

Increase in health concerns over radiation exposure and rise in use of diagnostic imaging modalities

Which was the most lucrative region for radiation dose management industry in 2022?

North America was the most lucrative region in 2022

Who are the prominent radiation dose management service providers?

Landauer, Agfa-Gevaert Group, Sectra AB, INFINITT Healthcare Co. Ltd., Bayer AG, PACSHealth, LLC, Koninklijke Philips N.V., GE Healthcare, Thermo Fisher Scientific Inc., Medsquare SAS, Siemens, Fujifilm Holdings Corporation, and QAELUM NV

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Radiation Dose Management Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Product Definition

            4.1.2. Industry Evolution / Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Radiation Dose Management Market Analysis and Forecast, 2017-2031

    5. Key Insights

        5.1. Pipeline Analysis

        5.2. Key Product/Brand Analysis

        5.3. Key Mergers & Acquisitions

        5.4. COVID-19 Pandemic Impact on Industry

    6. Global Radiation Dose Management Market Analysis and Forecast, by Product and Services

        6.1. Introduction and Definitions

        6.2. Key Findings/Developments

        6.3. Market Value Forecast, by Product and Services, 2017–2031

            6.3.1. Software

                6.3.1.1. Integrated Solution

                6.3.1.2. Standalone Solution

            6.3.2. Services

        6.4. Market Attractiveness, by Product and Services

    7. Global Radiation Dose Management Market Analysis and Forecast, by Modality

        7.1. Introduction and Definitions

        7.2. Key Findings/Developments

        7.3. Market Value Forecast, by Modality, 2017–2031

            7.3.1. Computed Tomography

            7.3.2. Radiography and Mammography

            7.3.3. Fluoroscopy and Interventional Imaging

            7.3.4. Nuclear Medicine Scan

            7.3.5. Others

            7.3.6. 7.4 Market Attractiveness, by Modality

    8. Global Radiation Dose Management Market Analysis and Forecast, by Application

        8.1. Introduction and Definitions

        8.2. Key Findings/Developments

        8.3. Market Value Forecast, by Application, 2017–2031

            8.3.1. Oncology

            8.3.2. Cardiology

            8.3.3. Orthopedic

            8.3.4. Others

        8.4. Market Attractiveness, by Application

    9. Global Radiation Dose Management Market Analysis and Forecast, by End-user

        9.1. Introduction and Definitions

        9.2. Key Findings/Developments

        9.3. Market Value Forecast, by End-user, 2017–2031

            9.3.1. Hospitals

            9.3.2. Ambulatory Care Settings

            9.3.3. Research Organizations

            9.3.4. Others

        9.4. Market Attractiveness, by End-user

    10. Global Radiation Dose Management Market Analysis and Forecast, by Region

        10.1. Key Findings

        10.2. Market Value Forecast, by Region, 2017–2031

            10.2.1. North America

            10.2.2. Europe

            10.2.3. Asia Pacific

            10.2.4. Latin America

            10.2.5. Middle East & Africa

        10.3. Market Attractiveness, by Region

    11. North America Radiation Dose Management Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Market Value Forecast, by Product and Services, 2017–2031

            11.2.1. Software

                11.2.1.1. Integrated Solution

                11.2.1.2. Standalone Solution

            11.2.2. Services

        11.3. Market Attractiveness, by Product and Services

        11.4. Market Value Forecast, by Modality, 2017–2031

            11.4.1. Computed Tomography

            11.4.2. Radiography and Mammography

            11.4.3. Fluoroscopy and Interventional Imaging

            11.4.4. Nuclear Medicine Scan

            11.4.5. Others

        11.5. Market Attractiveness, by Modality

        11.6. Market Value Forecast, by Application, 2017–2031

            11.6.1. Oncology

            11.6.2. Cardiology

            11.6.3. Orthopedic

            11.6.4. Others

        11.7. Market Attractiveness, by Application

        11.8. Market Value Forecast, by End-user, 2017–2031

            11.8.1. Hospitals

            11.8.2. Ambulatory Care Settings

            11.8.3. Research Organizations

            11.8.4. Others

        11.9. Market Attractiveness, by End-user

        11.10. Market Value Forecast, by Country/Sub-region, 2017–2031

            11.10.1. U.S.

            11.10.2. Canada

        11.11. Market Attractiveness Analysis

            11.11.1. By Product and Services

            11.11.2. By Modality

            11.11.3. By Application

            11.11.4. By End-user

            11.11.5. By Country

    12. Europe Radiation Dose Management Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Market Value Forecast, by Product and Services, 2017–2031

            12.2.1. Software

                12.2.1.1. Integrated Solution

                12.2.1.2. Standalone Solution

            12.2.2. Services

        12.3. Market Attractiveness, by Product and Services

        12.4. Market Value Forecast, by Modality, 2017–2031

            12.4.1. Computed Tomography

            12.4.2. Radiography and Mammography

            12.4.3. Fluoroscopy and Interventional Imaging

            12.4.4. Nuclear Medicine Scan

            12.4.5. Others

        12.5. Market Attractiveness, by Modality

        12.6. Market Value Forecast, by Application, 2017–2031

            12.6.1. Oncology

            12.6.2. Cardiology

            12.6.3. Orthopedic

            12.6.4. Others

        12.7. Market Attractiveness, by Application

        12.8. Market Value Forecast, by End-user, 2017–2031

            12.8.1. Hospitals

            12.8.2. Ambulatory Care Settings

            12.8.3. Research Organizations

            12.8.4. Others

        12.9. Market Attractiveness, by End-user

        12.10. Market Value Forecast, by Country/Sub-region, 2017–2031

            12.10.1. Germany

            12.10.2. U.K.

            12.10.3. France

            12.10.4. Italy

            12.10.5. Spain

            12.10.6. Rest of Europe

        12.11. Market Attractiveness Analysis

            12.11.1. By Product and Services

            12.11.2. By Modality

            12.11.3. By Application

            12.11.4. By End-user

            12.11.5. By Country/Sub-region

    13. Asia Pacific Radiation Dose Management Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Market Value Forecast, by Product and Services, 2017–2031

            13.2.1. Software

                13.2.1.1. Integrated Solution

                13.2.1.2. Standalone Solution

            13.2.2. Services

        13.3. Market Attractiveness, by Product and Services

        13.4. Market Value Forecast, by Modality, 2017–2031

            13.4.1. Computed Tomography

            13.4.2. Radiography and Mammography

            13.4.3. Fluoroscopy and Interventional Imaging

            13.4.4. Nuclear Medicine Scan

            13.4.5. Others

        13.5. Market Attractiveness, by Modality

        13.6. Market Value Forecast, by Application, 2017–2031

            13.6.1. Oncology

            13.6.2. Cardiology

            13.6.3. Orthopedic

            13.6.4. Others

        13.7. Market Attractiveness, by Application

        13.8. Market Value Forecast, by End-user, 2017–2031

            13.8.1. Hospitals

            13.8.2. Ambulatory Care Settings

            13.8.3. Research Organizations

            13.8.4. Others

        13.9. Market Attractiveness, by End-user

        13.10. Market Value Forecast, by Country/Sub-region, 2017–2031

            13.10.1. China

            13.10.2. Japan

            13.10.3. India

            13.10.4. Australia & New Zealand

            13.10.5. Rest of Asia Pacific

        13.11. Market Attractiveness Analysis

            13.11.1. By Product and Services

            13.11.2. By Modality

            13.11.3. By Application

            13.11.4. By End-user

            13.11.5. By Country/Sub-region

    14. Latin America Radiation Dose Management Market Analysis and Forecast

        14.1. Introduction

            14.1.1. Key Findings

        14.2. Market Value Forecast, by Product and Services, 2017–2031

            14.2.1. Software

                14.2.1.1. Integrated Solution

                14.2.1.2. Standalone Solution

            14.2.2. Services

        14.3. Market Attractiveness, by Product and Services

        14.4. Market Value Forecast, by Modality, 2017–2031

            14.4.1. Computed Tomography

            14.4.2. Radiography and Mammography

            14.4.3. Fluoroscopy and Interventional Imaging

            14.4.4. Nuclear Medicine Scan

            14.4.5. Others

        14.5. Market Attractiveness, by Modality

        14.6. Market Value Forecast, by Application, 2017–2031

            14.6.1. Oncology

            14.6.2. Cardiology

            14.6.3. Orthopedic

            14.6.4. Others

        14.7. Market Attractiveness, by Application

        14.8. Market Value Forecast, by End-user, 2017–2031

            14.8.1. Hospitals

            14.8.2. Ambulatory Care Settings

            14.8.3. Research Organizations

            14.8.4. Others

        14.9. Market Attractiveness, by End-user

        14.10. Market Value Forecast, by Country/Sub-region, 2017–2031

            14.10.1. Brazil

            14.10.2. Mexico

            14.10.3. Rest of Latin America

        14.11. Market Attractiveness Analysis

            14.11.1. By Product and Services

            14.11.2. By Modality

            14.11.3. By Application

            14.11.4. By End-user

            14.11.5. By Country/Sub-region

    15. Middle East & Africa Radiation Dose Management Market Analysis and Forecast

        15.1. Introduction

            15.1.1. Key Findings

        15.2. Market Value Forecast, by Product and Services, 2017–2031

            15.2.1. Software

                15.2.1.1. Integrated Solution

                15.2.1.2. Standalone Solution

            15.2.2. Services

        15.3. Market Attractiveness, by Product and Services

        15.4. Market Value Forecast, by Modality, 2017–2031

            15.4.1. Computed Tomography

            15.4.2. Radiography and Mammography

            15.4.3. Fluoroscopy and Interventional Imaging

            15.4.4. Nuclear Medicine Scan

            15.4.5. Others

        15.5. Market Attractiveness, by Modality

        15.6. Market Value Forecast, by Application, 2017–2031

            15.6.1. Oncology

            15.6.2. Cardiology

            15.6.3. Orthopedic

            15.6.4. Others

        15.7. Market Attractiveness, by Application

        15.8. Market Value Forecast, by End-user, 2017–2031

            15.8.1. Hospitals

            15.8.2. Ambulatory Care Settings

            15.8.3. Research Organizations

            15.8.4. Others

        15.9. Market Attractiveness, by End-user

        15.10. Market Value Forecast, by Country/Sub-region, 2017–2031

            15.10.1. GCC Countries

            15.10.2. South Africa

            15.10.3. Rest of Middle East & Africa

        15.11. Market Attractiveness Analysis

            15.11.1. By Product and Services

            15.11.2. By Modality

            15.11.3. By Application

            15.11.4. By End-user

            15.11.5. By Country/Sub-region

    16. Competition Landscape

        16.1. Market Player -Competition Matrix (By Tier and Size of Companies)

        16.2. Market Share Analysis, by Company (2022)

        16.3. Company Profiles

            16.3.1. Landauer

                16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.1.2. Product Portfolio

                16.3.1.3. Financial Overview

                16.3.1.4. SWOT Analysis

                16.3.1.5. Strategic Overview

            16.3.2. Agfa-Gevaert Group

                16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.2.2. Product Portfolio

                16.3.2.3. Financial Overview

                16.3.2.4. SWOT Analysis

                16.3.2.5. Strategic Overview

            16.3.3. Sectra AB

                16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.3.2. Product Portfolio

                16.3.3.3. Financial Overview

                16.3.3.4. SWOT Analysis

                16.3.3.5. Strategic Overview

            16.3.4. INFINITT Healthcare Co. Ltd.

                16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.4.2. Product Portfolio

                16.3.4.3. Financial Overview

                16.3.4.4. SWOT Analysis

                16.3.4.5. Strategic Overview

            16.3.5. Bayer AG

                16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.5.2. Product Portfolio

                16.3.5.3. Financial Overview

                16.3.5.4. SWOT Analysis

                16.3.5.5. Strategic Overview

            16.3.6. PACSHealth, LLC

                16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.6.2. Product Portfolio

                16.3.6.3. Financial Overview

                16.3.6.4. SWOT Analysis

                16.3.6.5. Strategic Overview

            16.3.7. Koninklijke Philips N.V.

                16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.7.2. Product Portfolio

                16.3.7.3. Financial Overview

                16.3.7.4. SWOT Analysis

                16.3.7.5. Strategic Overview

            16.3.8. GE Healthcare

                16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.8.2. Product Portfolio

                16.3.8.3. Financial Overview

                16.3.8.4. SWOT Analysis

                16.3.8.5. Strategic Overview

            16.3.9. Thermo Fisher Scientific, Inc.

                16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.9.2. Product Portfolio

                16.3.9.3. Financial Overview

                16.3.9.4. SWOT Analysis

                16.3.9.5. Strategic Overview

            16.3.10. Medsquare SAS

                16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.10.2. Product Portfolio

                16.3.10.3. Financial Overview

                16.3.10.4. SWOT Analysis

                16.3.10.5. Strategic Overview

            16.3.11. Siemens

                16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.11.2. Product Portfolio

                16.3.11.3. Financial Overview

                16.3.11.4. SWOT Analysis

                16.3.11.5. Strategic Overview

            16.3.12. Fujifilm Holdings Corporation

                16.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.12.2. Product Portfolio

                16.3.12.3. Financial Overview

                16.3.12.4. SWOT Analysis

                16.3.12.5. Strategic Overview

            16.3.13. QAELUM NV

                16.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.13.2. Product Portfolio

                16.3.13.3. Financial Overview

                16.3.13.4. SWOT Analysis

                16.3.13.5. Strategic Overview

    List of Tables

    Table 01: Global Radiation Dose Management Market Size (US$ Mn) Forecast, by Product and Services, 2017–2031

    Table 02: Global Radiation Dose Management Market Size (US$ Mn) Forecast, by Modality, 2017–2031

    Table 03: Global Radiation Dose Management Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    Table 04: Global Radiation Dose Management Market Size (US$ Mn) Forecast, by Application, 2017–2031

    Table 05: Global Radiation Dose Management Market Size (US$ Mn) Forecast, by Region, 2017–2031

    Table 06: North America Radiation Dose Management Market Size (US$ Mn) Forecast, by Country, 2017–2031

    Table 07: North America Radiation Dose Management Market Size (US$ Mn) Forecast, by Product and Services, 2017–2031

    Table 08: North America Radiation Dose Management Market Size (US$ Mn) Forecast, by Modality, 2017–2031

    Table 9: North America Radiation Dose Management Market Size (US$ Mn) Forecast, by Application, 2017–2031

    Table 10: North America Radiation Dose Management Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    Table 11: Europe Radiation Dose Management Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 12: Europe Radiation Dose Management Market Size (US$ Mn) Forecast, by Product and Services, 2017–2031

    Table 13: Europe Radiation Dose Management Market Size (US$ Mn) Forecast, by Modality, 2017–2031

    Table 14: Europe Radiation Dose Management Market Size (US$ Mn) Forecast, by Application, 2017–2031

    Table 15: Europe Radiation Dose Management Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    Table 16: Asia Pacific Radiation Dose Management Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 17: Asia Pacific Radiation Dose Management Market Size (US$ Mn) Forecast, by Product and Services, 2017–2031

    Table 18: Asia Pacific Radiation Dose Management Market Size (US$ Mn) Forecast, by Modality, 2017–2031

    Table 19: Asia Pacific Radiation Dose Management Market Size (US$ Mn) Forecast, by Application, 2017–2031

    Table 20: Asia Pacific Radiation Dose Management Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    Table 21: Latin America Radiation Dose Management Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 22: Latin America Radiation Dose Management Market Size (US$ Mn) Forecast, by Product and Services, 2017–2031

    Table 23: Latin America Radiation Dose Management Market Size (US$ Mn) Forecast, by Modality, 2017–2031

    Table 24: Latin America Radiation Dose Management Market Size (US$ Mn) Forecast, by Application, 2017–2031

    Table 25: Latin America Radiation Dose Management Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    Table 26: Middle East & Africa Radiation Dose Management Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 27: Middle East & Africa Radiation Dose Management Market Size (US$ Mn) Forecast, by Product and Services, 2017–2031

    Table 28: Middle East & Africa Radiation Dose Management Market Size (US$ Mn) Forecast, by Modality, 2017–2031

    Table 29: Middle East & Africa Radiation Dose Management Market Size (US$ Mn) Forecast, by Application, 2017–2031

    Table 30: Middle East & Africa Radiation Dose Management Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    List of Figures

    Figure 01: Global Radiation Dose Management Market Size (US$ Mn), by Region, 2022 and 2031

    Figure 02: Global Radiation Dose Management Market Revenue (US$ Mn), by Product and Services, 2022

    Figure 03: Global Radiation Dose Management Market Value Share, by Product and Services, 2022

    Figure 04: Global Radiation Dose Management Market Revenue (US$ Mn), by Modality, 2022

    Figure 05: Global Radiation Dose Management Market Value Share, by Modality, 2022

    Figure 06: Global Radiation Dose Management Market Revenue (US$ Mn), by Application, 2022

    Figure 07: Global Radiation Dose Management Market Value Share, by Application, 2022

    Figure 08: Global Radiation Dose Management Market Revenue (US$ Mn), by End-user, 2022

    Figure 09: Global Radiation Dose Management Market Value Share, by End-user, 2022

    Figure 10: Global Radiation Dose Management Market Value Share, by Region, 2022

    Figure 11: Global Radiation Dose Management Market Value (US$ Mn) Forecast, 2017–2031

    Figure 12: Global Radiation Dose Management Market Value Share Analysis, by Product and Services, 2022 and 2031

    Figure 13: Global Radiation Dose Management Market Attractiveness Analysis, by Product and Services, 2023-2031

    Figure 14: Global Radiation Dose Management Market Value Share Analysis, by Modality, 2022 and 2031

    Figure 15: Global Radiation Dose Management Market Attractiveness Analysis, by Modality, 2023-2031

    Figure 16: Global Radiation Dose Management Market Value Share Analysis, by Application, 2022 and 2031

    Figure 17: Global Radiation Dose Management Market Attractiveness Analysis, by Application, 2023-2031

    Figure 18: Global Radiation Dose Management Market Revenue (US$ Mn), by End-user, 2022

    Figure 19: Global Radiation Dose Management Market Value Share, by End-user, 2022

    Figure 20: Global Radiation Dose Management Market Value Share Analysis, by Region, 2022 and 2031

    Figure 21: Global Radiation Dose Management Market Attractiveness Analysis, by Region, 2023-2031

    Figure 22: North America Radiation Dose Management Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 23: North America Radiation Dose Management Market Attractiveness Analysis, by Country, 2023–2031

    Figure 24: North America Radiation Dose Management Market Value Share Analysis, by Country, 2022 and 2031

    Figure 25: North America Radiation Dose Management Market Value Share Analysis, by Product and Services, 2022 and 2031

    Figure 26: North America Radiation Dose Management Market Value Share Analysis, by Modality, 2022 and 2031

    Figure 27: North America Radiation Dose Management Market Value Share Analysis, by Application, 2022 and 2031

    Figure 28: North America Radiation Dose Management Market Value Share Analysis, by End-user, 2022 and 2031

    Figure 29: North America Radiation Dose Management Market Attractiveness Analysis, by Product and Services, 2023–2031

    Figure 30: North America Radiation Dose Management Market Attractiveness Analysis, by Modality, 2023–2031

    Figure 31: North America Radiation Dose Management Market Attractiveness Analysis, by Application, 2023–2031

    Figure 32: North America Radiation Dose Management Market Attractiveness Analysis, by End-user, 2023–2031

    Figure 33: Europe Radiation Dose Management Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 34: Europe Radiation Dose Management Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 35: Europe Radiation Dose Management Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 36: Europe Radiation Dose Management Market Value Share Analysis, by Product and Services, 2022 and 2031

    Figure 37: Europe Radiation Dose Management Market Value Share Analysis, by Modality, 2022 and 2031

    Figure 38: Europe Radiation Dose Management Market Value Share Analysis, by Application, 2022 and 2031

    Figure 39: Europe Radiation Dose Management Market Value Share Analysis, by End-user, 2022 and 2031

    Figure 40: Europe Radiation Dose Management Market Attractiveness Analysis, by Product and Services, 2023–2031

    Figure 41: Europe Radiation Dose Management Market Attractiveness Analysis, by Modality, 2023–2031

    Figure 42: Europe Radiation Dose Management Market Attractiveness Analysis, by Application, 2023–2031

    Figure 43: Europe Radiation Dose Management Market Attractiveness Analysis, by End-user, 2023–2031

    Figure 44: Asia Pacific Radiation Dose Management Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 45: Asia Pacific Radiation Dose Management Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 46: Asia Pacific Radiation Dose Management Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 47: Asia Pacific Radiation Dose Management Market Value Share Analysis, by Product and Services, 2022 and 2031

    Figure 48: Asia Pacific Radiation Dose Management Market Value Share Analysis, by Modality, 2022 and 2031

    Figure 49: Asia Pacific Radiation Dose Management Market Value Share Analysis, by Application, 2022 and 2031

    Figure 50: Asia Pacific Radiation Dose Management Market Value Share Analysis, by End-user, 2022 and 2031

    Figure 51: Asia Pacific Radiation Dose Management Market Attractiveness Analysis, by Product and Services, 2023–2031

    Figure 52: Asia Pacific Radiation Dose Management Market Attractiveness Analysis, by Modality, 2023–2031

    Figure 53: Asia Pacific Radiation Dose Management Market Attractiveness Analysis, by Application, 2023–2031

    Figure 54: Asia Pacific Radiation Dose Management Market Attractiveness Analysis, by End-user, 2022–2031

    Figure 55: Latin America Radiation Dose Management Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 56: Latin America Radiation Dose Management Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 57: Latin America Radiation Dose Management Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 58: Latin America Radiation Dose Management Market Value Share Analysis, by Product and Services, 2022 and 2031

    Figure 59: Latin America Radiation Dose Management Market Value Share Analysis, by Modality, 2022 and 2031

    Figure 60: Latin America Radiation Dose Management Market Value Share Analysis, by Application, 2022 and 2031

    Figure 61: Latin America Radiation Dose Management Market Value Share Analysis, by End-user, 2022 and 2031

    Figure 62: Latin America Radiation Dose Management Market Attractiveness Analysis, by Product and Services, 2023–2031

    Figure 63: Latin America Radiation Dose Management Market Attractiveness Analysis, by Modality, 2023–2031

    Figure 64: Latin America Radiation Dose Management Market Attractiveness Analysis, by Application, 2023–2031

    Figure 65: Latin America Radiation Dose Management Market Attractiveness Analysis, by End-user, 2023–2031

    Figure 66: Middle East & Africa Radiation Dose Management Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 67: Middle East & Africa Radiation Dose Management Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 68: Middle East & Africa Radiation Dose Management Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 69: Middle East & Africa Radiation Dose Management Market Value Share Analysis, by Product and Services, 2022 and 2031

    Figure 70: Middle East & Africa Radiation Dose Management Market Value Share Analysis, by Modality, 2022 and 2031

    Figure 71: Middle East & Africa Radiation Dose Management Market Value Share Analysis, by Application, 2022 and 2031

    Figure 72: Middle East & Africa Radiation Dose Management Market Value Share Analysis, by End-user, 2022 and 2031

    Figure 73: Middle East & Africa Radiation Dose Management Market Attractiveness Analysis, by Product and Services, 2023–2031

    Figure 74: Middle East & Africa Radiation Dose Management Market Attractiveness Analysis, by Modality, 2023–2031

    Figure 75: Middle East & Africa Radiation Dose Management Market Attractiveness Analysis, by Application, 2023–2031

    Figure 76: Middle East & Africa Radiation Dose Management Market Attractiveness Analysis, by End-user, 2023–2031

Copyright © Transparency Market Research, Inc. All Rights reserved